CORRECTION: On Friday, Unicycive Therapeutics Reported Q4 EPS Of $(0.22), Which Missed $(0.17) Estimate
CORRECTION: On Friday, Unicycive Therapeutics Reported Q4 EPS Of $(0.22), Which Missed $(0.17) Estimate
更正：周五，Unicycive Therapeutics公布的第四季度每股收益为0.22美元（0.22美元），未达到预期（0.17美元）
Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.17) by 29.41 percent. This is a 56.86 percent increase over losses of $(0.51) per share from the same period last year.
Unicycive Therapeutics（纳斯达克股票代码：UNCY）公布的季度亏损为每股0.22美元，比分析师普遍预期的0.17美元（0.17美元）低29.41％。与去年同期每股亏损0.51美元（0.51美元）相比，增长了56.86％。